The UK’s medical establishment is facing unprecedented internal dissent as hundreds of physicians have endorsed a petition demanding the resignation of General Medical Council (GMC) leadership. The controversy centers on the regulator’s persistent pursuit of Dr. Ghassan Abu Sittah, a prominent British-Palestinian surgeon, despite his complete exoneration by an independent tribunal.
The Medical Practitioners Tribunal had previously dismissed allegations that Dr. Abu Sittah’s writings demonstrated support for terrorism, specifically rejecting claims made by UK Lawyers for Israel (UKLFI) regarding an article in Lebanon’s Al Akhbar newspaper and social media posts. The tribunal found no evidence that patient safety was compromised or that professional standards were violated.
Despite this clearance, both the GMC and the Professional Standards Authority for Health and Social Care (PSA) have launched appeals to challenge the favorable ruling. The GMC’s legal expenditures in this case have reportedly surpassed £200,000—a sum requiring top-level authorization—raising additional concerns about financial governance within the organization.
Dr. Abu Sittah, who served as a volunteer surgeon in Gaza during the recent conflict and currently serves as rector of the University of Glasgow, condemns the appeals as “politically motivated” and part of a broader pattern of institutional weaponization. “These appeals show that civil society organisations have been commandeered by the pro-Israel lobby,” he stated, characterizing the actions as enabling genocide.
The case has ignited wider debates about medical professionals’ freedom of expression, particularly regarding international conflicts and humanitarian law. This month, 88% of delegates at the British Medical Association consultants conference endorsed a motion affirming doctors’ rights to speak on matters of public conscience.
The petition, organized by Health Workers 4 Palestine, draws parallels to the GMC’s heavily criticized handling of the Dr. Hadiza Bawa-Garba case, which previously prompted calls to remove the regulator’s power to appeal tribunal decisions—a reform recommended in 2018 but never implemented.
As the medical community remains divided, with the Doctors Association UK expressing disappointment in the PSA’s involvement, the High Court hearing date remains undetermined while the fundamental questions about regulatory overreach and professional free speech continue to reverberate throughout the UK healthcare system.